• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CATIE研究中精神分裂症的全基因组关联:第一阶段结果。

Genomewide association for schizophrenia in the CATIE study: results of stage 1.

作者信息

Sullivan P F, Lin D, Tzeng J-Y, van den Oord E, Perkins D, Stroup T S, Wagner M, Lee S, Wright F A, Zou F, Liu W, Downing A M, Lieberman J, Close S L

机构信息

Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7264, USA.

出版信息

Mol Psychiatry. 2008 Jun;13(6):570-84. doi: 10.1038/mp.2008.25. Epub 2008 Mar 18.

DOI:10.1038/mp.2008.25
PMID:18347602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3910086/
Abstract

Little is known for certain about the genetics of schizophrenia. The advent of genomewide association has been widely anticipated as a promising means to identify reproducible DNA sequence variation associated with this important and debilitating disorder. A total of 738 cases with DSM-IV schizophrenia (all participants in the CATIE study) and 733 group-matched controls were genotyped for 492,900 single-nucleotide polymorphisms (SNPs) using the Affymetrix 500K two-chip genotyping platform plus a custom 164K fill-in chip. Following multiple quality control steps for both subjects and SNPs, logistic regression analyses were used to assess the evidence for association of all SNPs with schizophrenia. We identified a number of promising SNPs for follow-up studies, although no SNP or multimarker combination of SNPs achieved genomewide statistical significance. Although a few signals coincided with genomic regions previously implicated in schizophrenia, chance could not be excluded. These data do not provide evidence for the involvement of any genomic region with schizophrenia detectable with moderate sample size. However, a planned genomewide association study for response phenotypes and inclusion of individual phenotype and genotype data from this study in meta-analyses hold promise for eventual identification of susceptibility and protective variants.

摘要

关于精神分裂症的遗传学,目前确切了解的还很少。全基因组关联研究的出现,被广泛期待为一种有前景的方法,用于识别与这种重要且使人衰弱的疾病相关的可重复DNA序列变异。使用Affymetrix 500K双芯片基因分型平台加上定制的164K填充芯片,对738例符合《精神疾病诊断与统计手册》第四版(DSM-IV)精神分裂症标准的患者(均为CATIE研究的参与者)和733名匹配的对照组进行了492,900个单核苷酸多态性(SNP)的基因分型。在对受试者和SNP进行多个质量控制步骤之后,采用逻辑回归分析来评估所有SNP与精神分裂症关联的证据。我们确定了一些有前景的SNP用于后续研究,尽管没有单个SNP或SNP的多标记组合达到全基因组统计学显著性。虽然有一些信号与先前涉及精神分裂症的基因组区域重合,但不能排除偶然性。这些数据没有提供证据表明,在中等样本量下可检测到任何基因组区域与精神分裂症有关。然而,一项针对反应表型的全基因组关联研究计划,以及将本研究中的个体表型和基因型数据纳入荟萃分析,有望最终识别出易感性和保护性变异。

相似文献

1
Genomewide association for schizophrenia in the CATIE study: results of stage 1.CATIE研究中精神分裂症的全基因组关联:第一阶段结果。
Mol Psychiatry. 2008 Jun;13(6):570-84. doi: 10.1038/mp.2008.25. Epub 2008 Mar 18.
2
Evidence for rare and common genetic risk variants for schizophrenia at protein kinase C, alpha.精神分裂症蛋白激酶 C,α 中罕见和常见遗传风险变异的证据。
Mol Psychiatry. 2010 Nov;15(11):1101-11. doi: 10.1038/mp.2009.96. Epub 2009 Sep 29.
3
Identification of novel candidate genes for treatment response to risperidone and susceptibility for schizophrenia: integrated analysis among pharmacogenomics, mouse expression, and genetic case-control association approaches.鉴定利培酮治疗反应和精神分裂症易感性的新型候选基因:药物基因组学、小鼠表达和遗传病例对照关联方法的综合分析。
Biol Psychiatry. 2010 Feb 1;67(3):263-9. doi: 10.1016/j.biopsych.2009.08.030. Epub 2009 Oct 22.
4
Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs.抗精神病药物代谢副作用的全基因组药物基因组学研究。
Mol Psychiatry. 2011 Mar;16(3):321-32. doi: 10.1038/mp.2010.14. Epub 2010 Mar 2.
5
Comparison of multimarker logistic regression models, with application to a genomewide scan of schizophrenia.多标志物逻辑回归模型的比较及其在精神分裂症全基因组扫描中的应用。
BMC Genet. 2010 Sep 9;11:80. doi: 10.1186/1471-2156-11-80.
6
Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia.GLI2 基因与慢性精神分裂症患者迟发性运动障碍的关联证据。
Mov Disord. 2010 Dec 15;25(16):2809-17. doi: 10.1002/mds.23377.
7
Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.全基因组药物基因组学分析抗精神病药物治疗反应。
Mol Psychiatry. 2011 Jan;16(1):76-85. doi: 10.1038/mp.2009.89. Epub 2009 Sep 1.
8
Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.与特发性肺纤维化易感性和死亡率相关的遗传变异:全基因组关联研究。
Lancet Respir Med. 2013 Jun;1(4):309-317. doi: 10.1016/S2213-2600(13)70045-6. Epub 2013 Apr 17.
9
Differential effects of common variants in SCN2A on general cognitive ability, brain physiology, and messenger RNA expression in schizophrenia cases and control individuals.SCN2A 常见变异对精神分裂症病例和对照个体的一般认知能力、大脑生理学和信使 RNA 表达的影响差异。
JAMA Psychiatry. 2014 Jun;71(6):647-56. doi: 10.1001/jamapsychiatry.2014.157.
10
No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics.在一个大型欧洲血统样本中,14个候选基因与精神分裂症无显著关联:对精神科遗传学的启示。
Am J Psychiatry. 2008 Apr;165(4):497-506. doi: 10.1176/appi.ajp.2007.07101573. Epub 2008 Jan 15.

引用本文的文献

1
Behavioural, psychiatric, and cognitive phenotypes associated with numbers of repeats of the FRAXE allele on the FMR2 gene.与FMR2基因上FRAXE等位基因重复次数相关的行为、精神和认知表型。
Wellcome Open Res. 2025 Apr 30;9:238. doi: 10.12688/wellcomeopenres.21305.2. eCollection 2024.
2
Classification of schizophrenia, bipolar disorder and major depressive disorder with comorbid traits and deep learning algorithms.精神分裂症、双相情感障碍和具有共病特征的重度抑郁症的分类及深度学习算法
Schizophrenia (Heidelb). 2025 Feb 5;11(1):14. doi: 10.1038/s41537-025-00564-7.
3
Machine Learning and Pharmacogenomics at the Time of Precision Psychiatry.精准精神医学时代的机器学习与药物基因组学
Curr Neuropharmacol. 2023;21(12):2395-2408. doi: 10.2174/1570159X21666230808170123.
4
Genome-wide association study identified six loci associated with adverse drug reactions to aripiprazole in schizophrenia patients.全基因组关联研究确定了六个与精神分裂症患者对阿立哌唑药物不良反应相关的基因座。
Schizophrenia (Heidelb). 2023 Jul 25;9(1):44. doi: 10.1038/s41537-023-00369-6.
5
Analysis of structural variation among inbred mouse strains.分析近交系小鼠品系间的结构变异。
BMC Genomics. 2023 Mar 2;24(1):97. doi: 10.1186/s12864-023-09197-5.
6
Imputed expression of schizophrenia-associated genes and cognitive measures in patients with schizophrenia.精神分裂症患者中与精神分裂症相关的基因表达与认知测量。
Mol Genet Genomic Med. 2022 Jun;10(6):e1942. doi: 10.1002/mgg3.1942. Epub 2022 Apr 30.
7
Artificial image objects for classification of schizophrenia with GWAS-selected SNVs and convolutional neural network.用于通过全基因组关联研究选择的单核苷酸变异和卷积神经网络对精神分裂症进行分类的人工图像对象
Patterns (N Y). 2021 Jun 30;2(8):100303. doi: 10.1016/j.patter.2021.100303. eCollection 2021 Aug 13.
8
Genome wide study of tardive dyskinesia in schizophrenia.精神分裂症迟发性运动障碍的全基因组研究。
Transl Psychiatry. 2021 Jun 8;11(1):351. doi: 10.1038/s41398-021-01471-y.
9
Polygenic Risk Scores for Subtyping of Schizophrenia.用于精神分裂症亚型分型的多基因风险评分
Schizophr Res Treatment. 2020 Jul 23;2020:1638403. doi: 10.1155/2020/1638403. eCollection 2020.
10
Approaches to studying the genomic architecture of complex birth defects.研究复杂出生缺陷基因组结构的方法。
Prenat Diagn. 2020 Aug;40(9):1047-1055. doi: 10.1002/pd.5760. Epub 2020 Jun 29.

本文引用的文献

1
The neuregulin 1 promoter polymorphism rs6994992 is not associated with chronic schizophrenia or neurocognition.神经调节蛋白1启动子多态性rs6994992与慢性精神分裂症或神经认知无关。
Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 5;147B(7):1298-300. doi: 10.1002/ajmg.b.30727.
2
Comment on a simple and improved correction for population stratification.关于一种简单且改进的群体分层校正方法的评论。
Am J Hum Genet. 2008 Feb;82(2):524-6; author reply 526-8. doi: 10.1016/j.ajhg.2007.10.014.
3
Controlling false discoveries in genetic studies.控制基因研究中的假阳性发现。
Am J Med Genet B Neuropsychiatr Genet. 2008 Jul 5;147B(5):637-44. doi: 10.1002/ajmg.b.30650.
4
New models of collaboration in genome-wide association studies: the Genetic Association Information Network.全基因组关联研究中的新型合作模式:遗传关联信息网络
Nat Genet. 2007 Sep;39(9):1045-51. doi: 10.1038/ng2127.
5
Genome-wide association studies provide new insights into type 2 diabetes aetiology.全基因组关联研究为2型糖尿病的病因学提供了新的见解。
Nat Rev Genet. 2007 Sep;8(9):657-62. doi: 10.1038/nrg2178.
6
PLINK: a tool set for whole-genome association and population-based linkage analyses.PLINK:一个用于全基因组关联分析和基于群体的连锁分析的工具集。
Am J Hum Genet. 2007 Sep;81(3):559-75. doi: 10.1086/519795. Epub 2007 Jul 25.
7
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.对14000例七种常见疾病患者及3000例共享对照进行全基因组关联研究。
Nature. 2007 Jun 7;447(7145):661-78. doi: 10.1038/nature05911.
8
Replicating genotype-phenotype associations.复制基因型-表型关联。
Nature. 2007 Jun 7;447(7145):655-60. doi: 10.1038/447655a.
9
Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia.精神分裂症中假常染色体细胞因子受体基因位点的汇聚证据。
Mol Psychiatry. 2007 Jun;12(6):572-80. doi: 10.1038/sj.mp.4001983. Epub 2007 Mar 20.
10
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.在英国样本中对全基因组关联信号进行复制,揭示了2型糖尿病的风险位点。
Science. 2007 Jun 1;316(5829):1336-41. doi: 10.1126/science.1142364. Epub 2007 Apr 26.